You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 48 No. 3, September 1952 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

OCULAR INVOLVEMENT IN LYMPHOMATOUS DISEASE

ALVAN R. FEINSTEIN, M.D.; ARLINGTON C. KRAUSE, M.D.

AMA Arch Ophthalmol. 1952;48(3):328-337.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

OCULAR invlovement in lymphomatous disease has been a sufficiently uncommon event to warrant isolated and collected case reports at various intervals in the ophthalmologic literature. Until recent years, the ocular manifestations were usually reported as ophthalmologic entities, and little attention was given to the occurrence of systemic disease, either prior to or following ocular involvement.

The opinion commonly expressed in the older ophthalmologic literature is that isolated ocular lymphoma generally is not followed by systemic involvement. This stands in conflict with the more recent concepts that appearance of a lymphoma anywhere in the body heralds eventual lymphomatous dissemination, though it be many years distant.

The problem of whether a simple ocular lymphoma should be considered as the first manifestation of a systemic disease has not been settled. Since the ophthalmologist rarely has the privilege of seeing the patient who suffers systemic involvement without recurrent ophthalmic disease, the question is one . . . [Full Text PDF of this Article]


Author Affiliations

CHICAGO

From the University of Chicago, Department of Surgery, Division of Ophthalmology.


Footnotes

This work has been done in part under a grant from the Douglas Smith Foundation for Medical Research of the University of Chicago.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1952 American Medical Association. All Rights Reserved.